Please login to the form below

New opportunities in emerging markets

Published in Pharma Exec January 2018 by Rachel Howard

The next billion patients

Until recently, multinational pharmaceutical and life sciences companies have focused their clinical research efforts/clinical development programs almost exclusively on mature markets: North America, Europe and Japan in particular. However, rapid changes are underway in emerging markets.

Firstly, we are seeing an expanding middle class. Virtually every emerging market, from Indonesia to Mexico and from China to Brazil, is witnessing an increase in the proportion of patients who now qualify as middle class, and wealth is increasing commensurately, enabling more individuals to afford essential care or purchase private health insurance. This growth is set to continue. In parallel, we are seeing an increased focus among emerging market governments on public healthcare reform: expanding their populations’ access to medicines by establishing universal healthcare coverage (such as JKN in Indonesia and Seguro Popular in Mexico) and deepening access by expanding formularies to include more drugs (despite these often being set in the context of aggressive cost containment measures).

Greater purchasing power and improved market access are growing the opportunity for innovative medicines in these markets.  The vast populations of many emerging markets mean they constitute a high proportion of the world’s "next billion patients", which pharma simply cannot afford to overlook...

Read the full article: 
https://www.researchpartnership.com/news/2018/01/new-opportunities-in-emerging-markets/


9th February 2018

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Video
Virtual Conference Live
Research Partnership
Report
Digital Health Tools - Physician Trends
Research Partnership
Live webinar:
Oncology landscape: How innovative market research methods can navigate you to success
Research Partnership
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership
Research Partnership’s MedTech Division appoints two Directors
Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.
Research Partnership
Webcast: Influencing HCP behaviours – Is now the perfect opportunity?
Putting behavioural science at the forefront of market research
Research Partnership